Other studies have already indicated that T cells play an essential role in limiting tumor development and that in breast cancer, CD4+ and CD8+ infiltrating T cells are abundant in high-grade ductal carcinoma in situ as well as in invasive carcinoma [78,79,80]. This evidence concerns the gene CD8A and ductal breast carcinoma in situ.